FIG 1.

Motor complications comparison at baseline (T0) and follow‐up (T1). (A) Items 32 (dyskinesia duration) and 33 (dyskinesia disability), including male and female values and 39 (OFF‐time) at T0 and T1. (B) Distribution of single scores for item 32 (dyskinesia duration) and item 33 (dyskinesia disability) at T0 and T1. (C) Distribution (number of patients) of troublesome dyskinesia at baseline (T0) and follow‐up (T1), dyskinesia persistence, improvement. and new development for all patients (and stratified per gender). (D) Dyskinesia duration: 0 = none; 1%–25% of day; 2 = 26%–50% of day; 3 = 51%–75% of day; 4 = 76%–100% of day. Dyskinesia disability: 0 = not disabling; 1 = mildly disabling; 2 = moderately disabling; 3 = severely disabling; 4 = completely disabling.